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Recent transmission of dengue viruses has increased
in tropical and subtropical areas and in industrialized coun-
tries because of international travel. We describe a case of
nosocomial transmission of dengue virus in Germany by a
needlestick injury. Diagnosis was made by TaqMan reverse
transcription–polymerase chain reaction when serologic
studies were negative. 
D
engue viruses are transmitted by Aedes mosquitoes in
tropical regions worldwide. The global incidence of
epidemic and endemicdengue fever has increased substan-
tially and is estimated at 50–100 million cases per year.
International travel leads to imported cases in countries of
the Northern Hemisphere (1), where dengue fever is an
important differential diagnosis of fever in travelers return-
ing from the tropics. Occupational needlestick injuries
continue to pose a substantial risk for healthcare workers
and occur at rates of 1.0 to 6.2 per 100 person-years (2).
Common concerns are the transmission of HIV, hepatitis B
virus, and hepatitis C virus. However, other pathogens can
be transmitted as well. We report a case of nosocomial
transmission of dengue virus.
The Study
The index patient, a 26-year-old woman, was admitted
to the infectious disease ward of a university hospital with
a temperature of 40°C and myalgias 3 days after she
returned from a 3-week trip to Cambodia and Thailand.
Dengue virus infection was subsequently diagnosed, and
mild hepatitis and a rash developed. She was discharged in
good condition after the fever subsided. On the day of
admission of the index patient (day 0i), a nurse sustained a
needlestick injury with a hollow needle that had been used
for drawing blood from the index patient. The needlestick
resulted in a bleeding puncture wound that was immediate-
ly treated with an antiseptic. The index patient did not
report any high-risk activity for HIV or hepatitis B virus,
and the nurse had been immunized against hepatitis B
virus. Therefore, no specific postexposure prophylaxis was
performed. The nurse had previously been in good health
and had not traveled outside Germany in the preceding 12
months.
Four days after the needlestick, headache, myalgias,
and arthralgias developed in the healthcare worker, for
which she took ibuprofen. Seven days later, when she was
experiencing an intense headache and noticed a macular
rash on her trunk, she sought treatment from a local doctor
(day 0n). Physical examination showed bilateral cervical
lymphadenopathy. On day 2n, she visited our service,
where dengue virus infection was diagnosed by using a
Light Cycler (Roche Diagnostics, Mannheim, Germany)
polymerase chain reaction (PCR) method. Her symptoms
lessened gradually over the course of 4 weeks, and she was
on sick leave for 5 weeks. The time frame of the respective
clinical presentation and the virologic results of the index
patient and the nurse are shown in the Figure; laboratory
data are presented in the Table. 
Serologic studies were performed with the PanBio
dengue immunoglobulin (Ig) M capture enzyme-linked
immunosorbent assay (ELISA) and PanBio dengue indi-
rect IgG ELISA (PanBio Ltd., Brisbane, Australia) (3);
arbitrary units relative to a simultaneously measured cali-
brator >11 were considered positive. For detecting virus
RNA, RNA was prepared from 140 µL of serum by using
the QIAamp Viral RNA Mini Kit (Qiagen, Hilden,
Germany), according to the manufacturer’s instructions.
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Figure. Time line of the signs, symptoms, and diagnostic tests in
the index patient (i) and nurse (n). Ig, immunoglobulin; PCR, poly-
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To detect specific dengue virus RNA, we adapted a
TaqMan-reverse transcription (RT)-PCR (4) to detect any
of the four serotypes by using the following: degenerated
forward primer (DEN FP), reverse primer (DEN RP); and
probe (DEN P): DEN FP 5′AAggACTAgAgg
TTAKAggAgACCC3′, DEN RP 5′ggCCYTCTgTgC
CTggAWTgATg3′ and the probe DEN P 5′ FAM-
AACAgCATATTgACgCTgggARAgACC-TAMRA-3′.
RT-PCR conditions for the Light Cycler (Roche
Diagnostics) were: RT at 61°C for 20 min, activation at
95°C for 5 min, and 40 cycles of PCR at 95°C for 15 s,
60°C for 60 s. We used the RNA Master Hybridization
Probes Kit (Roche Diagnostics) with 500-nM primers and
200-nM probes. The kit includes an aptamer-blocked
Thermus thermophilus DNA polymerase, which performs
RT and, once the aptamer drops out at activation, hotstarts
PCR amplification.
Conclusions
This is the fourth reported case, to our knowledge, of
nosocomial dengue virus transmission (5–7) and the first
in which TaqMan RT-PCR was used to provide evidence of
nosocomial transmission before the detection of an anti-
body response. The index patient had acquired a dengue
virus infection in Southeast Asia and experienced typical
symptoms. In particular, she was febrile on admission,
when the needlestick injury of the nurse occurred. In the
health care worker who sustained the injury, cephalgia and
myalgias developed after an incubation period of 4 days. A
typical rash appeared after 11 days, when she also had a
severe headache. The absence of fever, the most common
sign of dengue fever, is likely due to the administration of
ibuprofen. Both persons completely recovered. However,
the healthcare worker was on sick leave for 5 weeks with
resulting socioeconomic consequences.
The diagnosis was confirmed in both cases by both
seroconversion and detection of dengue viral RNA by
TaqMan RT-PCR; the latter gave positive results in both
cases 3 and 6 days, respectively, before serum specimens
were shown to contain antibody. Dengue viremia is known
to correlate well with the presence of fever (8), which was
the case in the index patient. Our report illustrates the
potential of percutaneous nosocomial transmission of
dengue viruses. This risk is likely to increase with the
increase in the number of dengue infections imported to
countries where dengue viruses are not endemic.
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